Diabetes Clinical Trials

Showing 4961-4980 of 7,874 trials

Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

NCT01154348

The purpose of this study is to determine the safety and pharmacokinetics of double-blind S-707106 alone and in combination with open-label metformin in patients with type 2 diabetes mellitus

Type 2 Diabetes Mellitus

Shionogi34 participantsStarted Jun 2010

San Antonio, Texas, United States

COMPLETEDPhase 2

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

NCT02526524

The purpose of the study is to compare the glycemic effects of delayed-release metformin (Met DR) to placebo in subjects with type 2 diabetes mellitus (T2DM) over 16 weeks. The study is designed to evaluate several doses of Met DR (600 to 1500 mg once daily in the morning \[qAM\]) compared to placebo. A single-blind reference treatment of 2000 mg metformin immediate-release (Met IR) per day administered as equal divided doses (1000 mg Met IR BID) will also be included.

Type 2 Diabetes Mellitus

Elcelyx Therapeutics, Inc.571 participantsStarted Sep 2015

Anniston, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +134 more locations

Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Related Searches

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

PeRsOnalising Treatment Of Diabetic Nephropathy:

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

A Mobile Phone-based Program for Adults With Prediabetes

The Effect of Lifestyle Intervention Versus Gastric Bypass on Various Comorbidities in Morbidly Obese Subjects

Predicting Response to Incretin Based Agents in Type 2 Diabetes

Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes

A Comparison of Computerised Versus Interviewer-administered Approach for Assessing Health-related Quality of Life

Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes

A Study in Participants With Type 2 Diabetes Mellitus

A Study for Patients With Type 1 Diabetes

Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis

Sequencing T-cells in Type I Diabetes Mellitus

A Study in Patients With Type 2 Diabetes Mellitus

Salivary Transcriptome Biomarkers for Early Diabetes Detection

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Evaluation of the EarEEG System for Detection of Hypoglycaemia-induced Changes in the EEG in Subjects With Type 1 Diabetes